Apollon Formularies (AQSE:APOL) Other Stockholders Equity : £-46.95 Mil (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Other Stockholders Equity?

Apollon Formularies's Other Stockholders Equity for the quarter that ended in Jun. 2023 was £-46.95 Mil.

Apollon Formularies's quarterly Other Stockholders Equity stayed the same from Dec. 2021 (£-46.95 Mil) to Jun. 2022 (£-46.95 Mil) and stayed the same from Jun. 2022 (£-46.95 Mil) to Jun. 2023 (£-46.95 Mil).

Apollon Formularies's annual Other Stockholders Equity declined from Dec. 2019 (£0.13 Mil) to Dec. 2020 (£0.00 Mil) and declined from Dec. 2020 (£0.00 Mil) to Dec. 2021 (£-46.95 Mil).

Apollon Formularies Other Stockholders Equity Historical Data

The historical data trend for Apollon Formularies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Other Stockholders Equity Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Other Stockholders Equity

Get a 7-Day Free Trial

0.29

0.26

0.13

-46.95

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Other Stockholders Equity	Get a 7-Day Free Trial											-	-47.03	-46.95	-46.95	-46.95

Apollon Formularies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Apollon Formularies Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.